99
|
Gilead Sciences
fraxiparine amp  Fraxiparine Amp, supplied by Gilead Sciences, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/adenosine+5%E2%80%99-+(cy%26methylene)triphosphate+apcpp/VEKLURY/pmc08753226-27-51-59 Average 99 stars, based on 1 article reviews
fraxiparine amp - by Bioz Stars,
2026-10
99/100 stars
|
Buy from Supplier |
95
|
Chem Impex International
2 17b amp 2 17b Amp, supplied by Chem Impex International, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/adenosine+5%E2%80%99-+(cy%26methylene)triphosphate+apcpp/Dicyclohexyl(1%2C1-diphenyl-1-propen-2-yl)phosphine/10__1111_slash_anu__13157-201-173-208 Average 95 stars, based on 1 article reviews
2 17b amp - by Bioz Stars,
2026-10
95/100 stars
|
Buy from Supplier |
N/A
|
The Recombinant Human Adenosylhomocysteinease AHCY Protein from R D Systems is derived from E coli The Recombinant Human Adenosylhomocysteinease AHCY Protein has been validated for the following applications Enzyme Activity
|
Buy from Supplier |
N/A
|
Bucladesine is a membrane permeable selective activator of PKA.An analog of cyclic AMP that stimulates cAMP-dependent protein kinase
|
Buy from Supplier |
N/A
|
N|6|-Monobutyryladenosine 3':5'-cyclic monophosphate sodium salt is an analog of cAMP which is membrane permeable and activates PKA. It is resistant to degradation via phosphodiesterase.
|
Buy from Supplier |
N/A
|
DescriptionDibutyryl CAMP is a cell-permeable CAMP analogue that activates CAMP dependent protein kinase (PKA) or the CAMP/PKA signaling pathway. Dibutyryl CAMP is used as a morphological differentiation inducer and cell signaling modulator in cells such
|
Buy from Supplier |
N/A
Image Search Results
Journal: SAGE Open Medical Case Reports
Article Title: The clinical course of a 79-year-old stroke survivor in the setting of a late-onset COVID-19 infection
doi: 10.1177/2050313X211066646
Figure Lengend Snippet: Lab results and therapy.
Article Snippet: 4 December , Respiratory rate , >26 , 12–16 , /min , , Another 10 day hospitalization due to breathing difficulties with wheezing: NaCl sol. 0.9% 100 mL, imipenem amp. 500 mg ×12 h; ciprofloxacin amp. ×12 h; pantoprazole amp. ×12 h; aminophylline amp. ×12 h; vitamin C amp. ×12 h;
Techniques: